Tag - pregnant

Provider Alert!
06Oct

Provider Alert! Case Management for Children and Pregnant Women (CPW) Carve-In

Date: October 5, 2022 Attention: All Providers Effective date: September 1, 2022 Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event.  TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event. Call to action: The purpose of this communication is to inform our providers of the Case Management for Children & Pregnant Women (CPW) carve-in to Medicaid that became...

By Events, Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , , , , 0 CommentsRead more...
25Apr

Texas Children’s Health Plan partners with Baylor College of Medicine to address and prevent opioid abuse in perinatal populations

Women of childbearing age have been disproportionately impacted by the opioid epidemic. Consequently, the rates of in utero drug exposure and Neonatal Abstinence Syndrome have increased dramatically over the last decade.  In Texas, overdose is the leading cause of maternal death in the first postpartum year. To prevent and respond to these issues, faculty from Baylor College of Medicine and Texas Children’s Health Plan were recently awarded funding from the Office of National Drug Control Policy’s grant program entitled Combating Opioid...

By OB/GYNs, , , , 0 CommentsRead more...
01Mar

Texas Children’s Health Plan partners with Baylor College of Medicine to address and prevent opioid abuse in perinatal populations

Women of childbearing age have been disproportionately impacted by the opioid epidemic. Consequently, the rates of in utero drug exposure and Neonatal Abstinence Syndrome have increased dramatically over the last decade.  In Texas, overdose is the leading cause of maternal death in the first postpartum year. To prevent and respond to these issues, faculty from Baylor College of Medicine and Texas Children’s Health Plan were recently awarded funding from the Office of National Drug Control Policy’s grant program entitled Combating Opioid...

By OB/GYNs, , , 0 CommentsRead more...
09Oct

Breaking Reminder: Syphilis Screening Urged for All Pregnant Women

The number of congenital syphilis cases is rising at an alarming rate.  From 2012-2016 the rate of congenital syphilis increased by 87% (from 8.4 to 15.7 cases per 100,000 live births).1   According to historical data, up to 40% of pregnancies with untreated syphilis will result in miscarriage, stillbirth, or infant death.  And those infants who live are at risk for skeletal abnormalities; hepatosplenomegaly; jaundice; anemia; and other complications which can cause developmental delays and seizures.2   Given that congenital syphilis is...

By OB/GYNs, , , , , , 0 CommentsRead more...
05Apr

Cesarean Delivery

This article presents new research and strategies to safely reduce the rate of primary Cesarean delivery. One out of three deliveries is by Cesarean.  In certain situations, Cesarean can be life-saving for both mother and baby.  But Cesarean deliveries aslo carry greater risks for mothers—research has shown that women who deliver their first baby by cesarean are more likely to need blood transfusions and be admitted to the ICU than women who have a vaginal delivery.  In addition, after that first...

By OB/GYNs, , , , , 0 CommentsRead more...
15Mar

Zika Virus and Pregnant Women

Everyone is talking about Zika! The virus is transmitted through infected mosquitos. Mexico, the Caribbean, Central America, along with parts of South America, have documented transmission of the virus and pregnant women who live in or travel to these areas are at risk of infection. Infection during pregnancy may or may not be accompanied by symptoms and has been associated with microcephaly. No treatment is available at this time. The most important thing to remember is that our knowledge about several...

By OB/GYNs, , , , , , 0 CommentsRead more...
01Sep

Provider Alert! Preventing Pre-Term Pregnancies

To: All Providers Subject: Effective September 1, 2015 all Progesterone therapy will require a pre-authorization from Texas Children’s Health Plan. Claims billed using the branded Makena will no longer require a U1 modifier. Pre-authorized use of Makena (hydroxyprogesterone caproate injection) will need to be submitted as J1725 with the appropriate NDC information as required on all claims. Claims billed using the compounded 17-P therapy will now require the U1 modifier. Pre-authorized use of 17-P will need to be submitted as J1725 with the...

By OB/GYNs, Provider Alert, , , , , , , 0 CommentsRead more...